Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection
Abstract Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide is a major public health concern. Cancer patients are considered a vulnerable population to SARS-CoV-2 infection and may develop several COVID-19 symptoms. The heig...
Main Authors: | Sima Chaudhari, Satyajit Dey Pereira, Meshach Asare-Warehene, Ritam Naha, Shama Prasada Kabekkodu, Benjamin K. Tsang, Kapaettu Satyamoorthy |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13048-021-00787-z |
Similar Items
-
The Role of Plasma Gelsolin in Epithelial Ovarian Cancer Chemoresistance
by: Asare-Werehene, Meshach
Published: (2020) -
Human Papillomavirus (HPV) Infection in Early Pregnancy: Prevalence and Implications
by: Deeksha Pandey, et al.
Published: (2019-01-01) -
Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancer
by: Hideaki Tsuyoshi, et al.
Published: (2020-05-01) -
Assessing Ovarian Reserve in Women After Laparoscopic Surgery for Ovarian Endometriosis
by: Tzu-Wei Liao, et al.
Published: (2004-09-01) -
Anticancer properties of recipes derived from nigeria and african medicinal plants on breast cancer cells in vitro
by: Mutiu A. Alabi, et al.
Published: (2020-07-01)